JP2007517188A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007517188A5 JP2007517188A5 JP2006539691A JP2006539691A JP2007517188A5 JP 2007517188 A5 JP2007517188 A5 JP 2007517188A5 JP 2006539691 A JP2006539691 A JP 2006539691A JP 2006539691 A JP2006539691 A JP 2006539691A JP 2007517188 A5 JP2007517188 A5 JP 2007517188A5
- Authority
- JP
- Japan
- Prior art keywords
- glur1
- seizure
- origin
- fragment
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 11
- 206010010904 Convulsion Diseases 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 4
- 239000013060 biological fluid Substances 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000010304 firing Methods 0.000 claims 2
- 206010036790 Productive cough Diseases 0.000 claims 1
- 230000002776 aggregation Effects 0.000 claims 1
- 238000004220 aggregation Methods 0.000 claims 1
- 230000001773 anti-convulsant effect Effects 0.000 claims 1
- 239000001961 anticonvulsive agent Substances 0.000 claims 1
- 229960003965 antiepileptics Drugs 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- 210000003802 sputum Anatomy 0.000 claims 1
- 208000024794 sputum Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51767103P | 2003-11-06 | 2003-11-06 | |
| US60/517,671 | 2003-11-06 | ||
| PCT/US2004/037088 WO2005046442A2 (en) | 2003-11-06 | 2004-11-08 | Immunosorbent tests for assessing paroxysmal cerebral discharges |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007517188A JP2007517188A (ja) | 2007-06-28 |
| JP2007517188A5 true JP2007517188A5 (enExample) | 2007-12-27 |
| JP4838140B2 JP4838140B2 (ja) | 2011-12-14 |
Family
ID=34590180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006539691A Expired - Fee Related JP4838140B2 (ja) | 2003-11-06 | 2004-11-08 | 発作性脳発射を評価するための免疫吸着血液検査 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7820398B2 (enExample) |
| EP (1) | EP1689288B1 (enExample) |
| JP (1) | JP4838140B2 (enExample) |
| CN (1) | CN1954211A (enExample) |
| AT (1) | ATE465412T1 (enExample) |
| AU (1) | AU2004288717A1 (enExample) |
| CA (1) | CA2585876A1 (enExample) |
| DE (1) | DE602004026767D1 (enExample) |
| EA (1) | EA200600920A1 (enExample) |
| WO (1) | WO2005046442A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6896872B2 (en) * | 2001-06-27 | 2005-05-24 | Svetlana A. Dambinova | Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke |
| US20060257943A1 (en) * | 2005-01-25 | 2006-11-16 | Cis Biotech, Inc. | Ischemic biomarkers and their use to predict adverse neurological events from surgery |
| CN101268370A (zh) * | 2005-06-13 | 2008-09-17 | Cis生物科技公司 | 基于nr2肽诊断和治疗脑血管事件的方法 |
| US8536115B2 (en) | 2006-08-31 | 2013-09-17 | Centre For Addiction And Mental Health | Compositions and methods for modulating AMPA receptor-mediated excitotoxicity |
| WO2013102264A1 (en) * | 2012-01-04 | 2013-07-11 | Centre For Addiction And Mental Health | Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| JP6298474B2 (ja) | 2012-12-17 | 2018-03-20 | レウコドゥックス，リミテッド | 生物学的状態を検出するシステムおよび方法 |
| US10610861B2 (en) | 2012-12-17 | 2020-04-07 | Accellix Ltd. | Systems, compositions and methods for detecting a biological condition |
| US9759722B2 (en) * | 2012-12-17 | 2017-09-12 | Leukodx Ltd. | Systems and methods for determining a chemical state |
| EP2863231A1 (en) * | 2013-10-17 | 2015-04-22 | Institut D'Investigaciones Biomédiques August Pi i Sunyer | Diagnostic method for detecting a GABA(A) related autoimmune disease and related subject-matter |
| US9958521B2 (en) | 2015-07-07 | 2018-05-01 | Q Bio, Inc. | Field-invariant quantitative magnetic-resonance signatures |
| US10194829B2 (en) | 2015-07-07 | 2019-02-05 | Q Bio, Inc. | Fast scanning based on magnetic resonance history |
| WO2017044919A1 (en) | 2015-09-12 | 2017-03-16 | Q Bio, Inc | Uniform-frequency records with obscured context |
| US10964412B2 (en) | 2015-10-20 | 2021-03-30 | Q Bio, Inc. | Population-based medical rules via anonymous sharing |
| US10359486B2 (en) | 2016-04-03 | 2019-07-23 | Q Bio, Inc. | Rapid determination of a relaxation time |
| US10222441B2 (en) | 2016-04-03 | 2019-03-05 | Q Bio, Inc. | Tensor field mapping |
| WO2018144044A1 (en) * | 2017-02-03 | 2018-08-09 | Q Bio, Inc. | lTERATIVE MEDICAL TESTING OF BIOLOGICAL SAMPLES |
| US11650195B2 (en) | 2017-02-03 | 2023-05-16 | Q Bio, Inc. | Iterative medical testing of biological samples |
| US10936180B2 (en) | 2017-03-16 | 2021-03-02 | Q Bio, Inc. | User interface for medical information |
| US11360166B2 (en) | 2019-02-15 | 2022-06-14 | Q Bio, Inc | Tensor field mapping with magnetostatic constraint |
| US11354586B2 (en) | 2019-02-15 | 2022-06-07 | Q Bio, Inc. | Model parameter determination using a predictive model |
| US20220196637A1 (en) | 2019-05-24 | 2022-06-23 | Fujirebio Inc. | Method and reagent for measuring thyroglobulin |
| EP4036111A4 (en) | 2019-09-27 | 2023-10-25 | Fujirebio Inc. | HEPATITIS B VIRUS CORE ANTIGEN IMMUNOASSAY AND KIT THEREOF |
| US11614509B2 (en) | 2019-09-27 | 2023-03-28 | Q Bio, Inc. | Maxwell parallel imaging |
| US12320880B2 (en) | 2019-09-27 | 2025-06-03 | Q Bio, Inc. | Maxwell parallel imaging |
| EP4034901A4 (en) | 2019-09-27 | 2023-11-01 | Q Bio, Inc | PARALLEL MAXWELL IMAGING |
| US20230160912A1 (en) | 2020-03-31 | 2023-05-25 | Fujirebio Inc. | Method for immunoassay of amyloid beta in blood, and kit for same |
| US20250147029A1 (en) | 2021-08-06 | 2025-05-08 | Advanced Life Science Institute, Inc. | Immunoassay for thyroglobulin and kit therefor |
| US11614508B1 (en) | 2021-10-25 | 2023-03-28 | Q Bio, Inc. | Sparse representation of measurements |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879289A (en) * | 1988-05-24 | 1989-11-07 | Marion Laboratories, Inc. | Method of ameliorating epileptic seizures |
| ATE265528T1 (de) * | 1989-10-27 | 2004-05-15 | Salk Inst For Biological Studi | Rezeptorverbindungen von glutamin und herstellung |
| WO1993000586A1 (fr) | 1991-06-26 | 1993-01-07 | Obschestvo S Ogranichennoi Otvetstvennostju 'dies' | Immunoadsorbant utilise dans le diagnostic de l'epilepsie et d'un groupe a risque |
| JP2782695B2 (ja) | 1992-09-11 | 1998-08-06 | ダムビノヴァ，スヴェトラーナ・アレクサンドロフナ | 神経症および精神病の診断用免疫吸着剤およびその実際的用途 |
| RU2112243C1 (ru) | 1995-11-29 | 1998-05-27 | Светлана Александровна Дамбинова | Набор "па-тест" для диагностики неврологических заболеваний |
| US6896872B2 (en) | 2001-06-27 | 2005-05-24 | Svetlana A. Dambinova | Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke |
| US20050233390A1 (en) * | 2003-04-09 | 2005-10-20 | Allen John W | Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| US20060257943A1 (en) | 2005-01-25 | 2006-11-16 | Cis Biotech, Inc. | Ischemic biomarkers and their use to predict adverse neurological events from surgery |
-
2004
- 2004-11-08 DE DE602004026767T patent/DE602004026767D1/de not_active Expired - Lifetime
- 2004-11-08 EA EA200600920A patent/EA200600920A1/ru unknown
- 2004-11-08 EP EP04818645A patent/EP1689288B1/en not_active Expired - Lifetime
- 2004-11-08 JP JP2006539691A patent/JP4838140B2/ja not_active Expired - Fee Related
- 2004-11-08 WO PCT/US2004/037088 patent/WO2005046442A2/en not_active Ceased
- 2004-11-08 AT AT04818645T patent/ATE465412T1/de not_active IP Right Cessation
- 2004-11-08 AU AU2004288717A patent/AU2004288717A1/en not_active Abandoned
- 2004-11-08 CA CA002585876A patent/CA2585876A1/en not_active Abandoned
- 2004-11-08 US US10/983,845 patent/US7820398B2/en not_active Expired - Fee Related
- 2004-11-08 CN CNA2004800399514A patent/CN1954211A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007517188A5 (enExample) | ||
| Dunjic-Kostic et al. | Melancholic and atypical major depression—connection between cytokines, psychopathology and treatment | |
| Kamiya et al. | Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy | |
| Kodama et al. | Influence of proton pump inhibitor treatment on Helicobacter pylori stool antigen test | |
| Raji et al. | Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake | |
| Domanico et al. | Circulating levels of reactive oxygen species in patients with nonproliferative diabetic retinopathy and the influence of antioxidant supplementation: 6-month follow-up | |
| US20110020789A1 (en) | Methods for assessing fatigue level and applications thereof | |
| KR20170062478A (ko) | 우울증 치료약의 선택지를 예측하는 방법 | |
| Kaplan et al. | Single-voided urine metanephrine assays in screening for pheochromocytoma | |
| Gustavsson et al. | Intoxication from an accidentally ingested lead shot retained in the gastrointestinal tract | |
| Liu et al. | Cardiac structure and function improvements in coronary artery disease combined with severe obstructive sleep apnea/hypopnea syndrome patients via noninvasive positive pressure ventilation therapy | |
| Lautrette et al. | High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis | |
| Prabhakar et al. | Non-compressive myelopathy: clinical and radiological study. | |
| Kagawa et al. | Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease: A case report | |
| RU2017129810A (ru) | Способ прогнозирования риска развития ожирения у субъекта | |
| Shin et al. | Association between salivary mitochondrial DNA copy number and chronic fatigue according to combined symptoms in Korean adults | |
| Kawaguchi et al. | Effects of a short-acting β1 receptor antagonist landiolol on hemodynamics and tissue injury markers in patients with subarachnoid hemorrhage undergoing intracranial aneurysm surgery | |
| Yale et al. | Anion gap acidosis associated with acetaminophen | |
| Seto et al. | Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database | |
| Matz | The target for good glycemic control should be an Hb A1C concentration of less than 0.07 | |
| Tonbul et al. | The importance of serum transferrin receptor level in the diagnosis of functional iron deficiency due to recombinant human erythropoietin treatment in haemodialysis patients | |
| Gallego et al. | Early changes in 24-hour ambulatory blood pressure are associated with high normal albumin excretion rate in children with type 1 diabetes mellitus | |
| Hachey et al. | Isolated elevation of alkaline phosphatase level associated with rosiglitazone | |
| RU2010126629A (ru) | Применение энтеровирусов для диагностики, лечения и профилактики | |
| Saumi et al. | Phytotherapy Nigella sativa lowers blood pressure in patients with stage 1 hypertension |